Polypharmacy Status as an Indicator of Mortality in an Elderly Population

被引:224
作者
Jyrkka, Johanna [1 ,2 ,3 ]
Enlund, Hannes [4 ]
Korhonen, Maarit J. [1 ,5 ]
Sulkava, Raimo [1 ]
Hartikainen, Sirpa [3 ,6 ,7 ]
机构
[1] Univ Kuopio, Sch Publ Hlth & Clin Nutr, FIN-70211 Kuopio, Finland
[2] Univ Kuopio, Dept Social Pharm, FIN-70211 Kuopio, Finland
[3] Univ Kuopio, Kuopio Res Ctr Geriatr Care, FIN-70211 Kuopio, Finland
[4] Kuwait Univ, Dept Pharm Practice, Kuwait, Kuwait
[5] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland
[6] Univ Kuopio, Fac Pharm, FIN-70211 Kuopio, Finland
[7] Leppavirta Hlth Ctr, Leppavirta, Finland
关键词
OLDER-PEOPLE; PRIMARY-CARE; DRUG-USE; HOME; PREDICTORS; HOSPITALIZATION; REVIEWS;
D O I
10.2165/11319530-000000000-00000
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: Increased use of drugs has raised concern about the risks of polypharmacy in elderly populations. Adverse outcomes, such as hospitalizations and falls, have been shown to be associated with polypharmacy. So far, little information is available on the association between polypharmacy status and mortality. Objective: To assess whether polypharmacy (six to nine drugs) or excessive polypharmacy (ten or more drugs) could be indicators of mortality in elderly persons. Methods: This was a population-based cohort study conducted between 1998 and 2003 with mortality follow-up through to 2007. The data in this study were derived from the population-based Kuopio 75+ Study, which involved elderly persons aged >= 75 years living in the city of Kuopio, Finland. The initial sample (sample frame n = 4518, random sample n = 700) was drawn from the population register. For the purpose of this study, two separate analyses were carried out. In the first phase, participants (aged >= 75 years, n=601) were followed from 1998 (baseline) to 2002. In the second phase, survivors (aged >= 80 years, n = 339) were followed from 2003 to 2007. Current medications were determined from drug containers and prescriptions during interviews conducted by a trained nurse. The Kaplan-Meier method and Cox proportional hazards regression were used to examine the association between polypharmacy status and mortality. Results: In the first phase, 28% (n = 167) belonged to the excessive polypharmacy group, 33% (n=200) to the polypharmacy group, and the remaining 39% (n=234) to the non-polypharmacy (0-5 drugs) group. The corresponding figures in the second phase were 28% (n = 95), 39% (n = 132) and 33% (n=112), respectively. The mortality rate was 37% in the first phase and 40% in the second phase. In both phases, the survival curves showed a significant difference in all-cause mortality between the three polypharmacy groups. In the first phase, the univariate model showed an association between excessive polypharmacy and mortality (hazard ratio [HR] 2.53, 95% CI 1.83, 3.48); however, after adjustment for demographics and other variables measuring functional and cognitive status, this association did not remain statistically significant (HR 1.28, 95% CI 0.86, 1.91). In the second phase, the association between excessive polypharmacy and mortality (HR 2.23, 95% Cl 1.21, 4.12) remained significant after adjustments. Age, male sex and dependency according to the Instrumental Activities of Daily Living screening instrument were associated with mortality in both phases. Conclusion: This study points to the importance of excessive polypharmacy as an indicator for mortality in elderly persons. This association needs to be confirmed following adjustment for co-morbidities.
引用
收藏
页码:1039 / 1048
页数:10
相关论文
共 41 条
  • [1] Factors predictive of outcome on admission to an acute geriatric ward
    Alarcón, T
    Bárcena, A
    González-Montalvo, JI
    Peñalosa, C
    Salgado, A
    [J]. AGE AND AGEING, 1999, 28 (05) : 429 - 432
  • [2] Inappropriate medication prescribing for the elderly by office-based physicians
    Aparasu, RR
    Fliginger, SE
    [J]. ANNALS OF PHARMACOTHERAPY, 1997, 31 (7-8) : 823 - 829
  • [3] Bassuk SS, 2000, AM J EPIDEMIOL, V151, P676
  • [4] Methods for estimating the occurrence of polypharmacy by means of a prescription database
    Bjerrum, L
    Rosholm, JU
    Hallas, J
    Kragstrup, J
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 53 (01) : 7 - 11
  • [5] BOLTON PGM, 2004, AUST J PRIM CARE, V10, P1
  • [6] Physical function and self-rated health status as predictors of mortality: Results from longitudinal analysis in the ilSIRENTE study
    Cesari M.
    Onder G.
    Zamboni V.
    Manini T.
    Shorr R.I.
    Russo A.
    Bernabei R.
    Pahor M.
    Landi F.
    [J]. BMC Geriatrics, 8 (1)
  • [7] Denneboom W, 2007, BRIT J GEN PRACT, V57, P723
  • [8] Denneboom W, 2006, BRIT J GEN PRACT, V56, P504
  • [9] Suboptimal medication use and mortality in an older adult community-based cohort: Results from the Hispanic EPESE study
    Espino, DV
    Bazaldua, OV
    Palmer, RF
    Mouton, CP
    Parchman, ML
    Miles, TP
    Markides, K
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2006, 61 (02): : 170 - 175
  • [10] A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting
    Finkers, F.
    Maring, J. G.
    Boersma, F.
    Taxis, K.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2007, 32 (05) : 469 - 476